Li, Zhenhui and Glenn I. Hatton. Histamine suppresses non-NMDA excitatory synaptic currents in rat supraoptic nucleus neurons. J. Neurophysiol. 83: 2616Neurophysiol. 83: -2625Neurophysiol. 83: , 2000. Whole cell patch-clamp recordings were obtained from supraoptic neurons to investigate the effects of histamine on excitatory postsynaptic currents evoked by electrical stimulation of areas around the posterior supraoptic nucleus. When cells were voltage-clamped at Ϫ70 mV, evoked excitatory postsynaptic currents had amplitudes of 88.4 Ϯ 9.6 pA and durations of 41.1 Ϯ 3.0 ms (mean Ϯ SE; n ϭ 43). With twin stimulus pulses (20 Hz) used, paired-pulse facilitation ratios were 1.93 Ϯ 0.12. Bath application of 6-cyano-7-nitroquinoxalene-2,3-dione (CNQX) abolished synaptic currents. Histamine at concentrations ϳ0.1-10 M reversibly suppressed excitatory postsynaptic currents in all supraoptic neurons tested. Within 2 min after application of (10 M) histamine, current amplitudes and durations decreased by 61.5 and 31.0%, respectively, with little change in the paired-pulse facilitation ratio. Dimaprit or imetit (H 2 or H 3 receptor agonists) did not reduce synaptic currents, whereas pyrilamine (H 1 receptor antagonist) blocked histamine-induced suppression of synaptic currents. When patch electrodes containing guanosine 5Ј-O-(2-thiodiphosphate) (GDP-␤-S) were used to record cells, histamine still suppressed current amplitudes by 49.1% and durations by 41.9%. Similarly, intracellular diffusion of bis-(o-aminophenoxy)-N,N,NЈ,NЈ-tetraacetic acid (BAPTA) and H 7 did not abolish histamine-induced suppression of synaptic currents, either. Bath perifusion of 8-bromo-quanosine 3Ј,5Ј-cyclic monophosphate reduced current amplitudes by 32.3% and durations by 27.9%. After bath perfusion of slices with N -nitro-L-arginine methyl ester (L-NAME), histamine injection decreased current amplitudes only by 31.9%, much less than the inhibition rate in control (P Ͻ 0.01). In addition, histamine induced little change in current durations and paired-pulse facilitation ratios, representing a partial blockade of histamine effects on synaptic currents by L-NAME. In supraoptic neurons recorded using electrodes containing BAPTA and perifused with L-NAME, the effects of histamine on synaptic currents were completely abolished. Norepinephrine injection reversibly decreased current amplitudes by 39.1% and duration by 64.5%, with a drop in the paired-pulse facilitation ratio of 47.9%. Bath perifusion of L-NAME, as well as intracellulardiffusionofGDP-␤-S,,1-(5-isoquinolinylsulfonyl)-2-methylpiperazine , or BAPTA, failed to block norepinephrine-induced suppression of evoked synaptic currents. The present results suggest that histamine suppresses non-N-methyl-D-aspartate synaptic currents in supraoptic neurons through activation of H 1 receptors. It is possible that histamine first acts at supraoptic cells (perhaps both neuronal and nonneuronal) and induces the production of nitric oxide, which then diffuses to nearby neurons and modulates synaptic transmission by a postsynaptic mechanism.
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I N T R O D U C T I O N
Histamine (HA) has been proposed to function both as a transmitter and a modulator in the brain (Hatton and Li 1998a; Prell and Green 1986) . Released from presynaptic terminals in response to electrical stimulation of the tuberomammillary nucleus (TM) or to dehydration (Akins and Bealer 1993; Kjaer et al. 1994) , HA not only elicits excitatory or inhibitory postsynaptic potentials (Weiss et al. 1989; Yang and Hatton 1994) but also regulates gap junctional communication (Hatton and Yang 1996) . The latter, as well as HA-induced prolonged depolarization and enhancement of depolarizing after potentials (DAPs) (Smith and Armstrong 1993; Yang and Hatton 1989) , is mediated by activation of various intracellular messenger systems (Leurs et al. 1995) . Our recent experiments demonstrated that prevention of G proteins, phospholipase C (PLC) or protein kinase C (PKC) from activation blocks HAinduced depolarization and enhancement of currents underlying depolarizing after potentials (I DAP ) (Li and Hatton 1996; Li et al. 1999) . Reduced nitric oxide (NO) production with inhibitors of NO synthase (NOS) cancels HA-induced increases in dye coupling among supraoptic nucleus (SON) neurons (Yang and Hatton 1999) .
The SON receives rich glutamatergic inputs that are critical in the regulation of hypothalamic neuroendocrine activity (Armstrong 1995; Hatton 1990; van den Pol et al. 1990 ). Glutamate can bind to postsynaptic non-N-methyl-D-aspartate (NMDA), mainly AMPA, and NMDA receptors to accomplish neurotransmission (Mayer and Westbrook 1987; Ozawa et al. 1998) . Activation of ionotropic glutamate receptors usually causes membrane depolarization and burst activities in SON neurons, resulting in increased release of both vasopressin and oxytocin (Gribkoff and Dudek 1990; Hu and Bourque 1992; Moos et al. 1997; Wuarin and Dudek 1993; Yang et al. 1995) . Because HA is known to modulate excitatory postsynaptic currents (EPSCs) in hippocampal neurons (Bekkers 1993; Brown et al. 1995; Nikmanesh et al. 1996; Saybasili et al. 1995) , here we examined whether HA influences non-NMDA glutamate receptor-mediated synaptic currents in SON neurons and explored possible intracellular mechanisms involved. For comparison, we also tested the effects of norepinephrine (NE) on synaptic currents. NE is another neurotransmitter that is reported to activate intracellular signal transduction systems similar to those used by HA (Armstrong 1995; Minneman and Esbenshade 1994) . The results showed that HA reversibly suppresses non-NMDA EPSCs via activating H 1 receptors, and NO is partially responsible for these actions of HA. A preliminary report of this study has appeared in abstract form (Hatton and Li 1998b) .
M E T H O D S

Preparation
Male rats, 50 -70 days, were decapitated using a rodent guillotine. Their brains were removed, and horizontal slices of the hypothalamus (250-to 300-m thick) were cut using a vibratome. Oxygenated (95% O 2 -5% CO 2 ) artificial cerebrospinal fluid (ACSF) contained (mM) 126 NaCl , 5 KCl, 1.3 NaHPO 4 , 2.4 CaCl 2 , 3.0, MgSO 4 , 26 NaHCO 3 , 10 glucose, and 5 3(N-morpholino)propanesulfonic acid buffer (310 mOsmol/l, pH 7.4). After incubation at room temperature (23°C) for Ͼ2 h, the slices were transferred to a submerging recording chamber and perifused with warmed ACSF (36°C) at 2 ml/min. To abolish GABAergic inhibitory synaptic inputs, bicuculline (10 -15 M) was added to the ACSF.
Electrophysiological recordings
Patch electrodes were pulled from borosilicate capillary tubing and filled with the following solution (mM): 140 K ϩ gluconate, 2 MgCl 2 ,10 HEPES, 2 K 2 ATP, and 0.4 Na 2 GTP (pH 7.25). Electrodes usually had outer tip diameters of ϳ2.7 m and DC resistances of 4 -5 M⍀. Whole cell patch-clamp recordings were obtained from SON neurons using an Axoclamp-2B amplifier (Axon Instruments, Foster City, CA). Patch electrodes approached the SON under visual guidance using a dissecting microscope. Whole cell recordings were obtained using current-clamp techniques. Hyperpolarizing currents were repeatedly passed to induce voltage responses that increased in amplitude when electrode tips touched neuronal membranes. Gigaohm seals between electrodes and cell membranes then were obtained by applying gentle suction. When a seal was achieved, further brief suction was applied to break through the membrane. Whole cell recordings were indicated by observation of negative membrane potentials and action potentials. KCl/agar bridges were used as reference electrodes and correction of liquid junction potential (Ϫ7 mV) was applied to recorded membrane voltages.
Continuous single-electrode voltage-clamp experiments were performed to investigate the EPSCs. Cells were clamped around Ϫ70 mV, and amplifier feedback gain was set at 40 -90 nA/mV and low-pass filter at 1.0 kHz. Series resistance was evaluated by measuring instantaneous currents evoked by a hyperpolarizing pulse (10 mV, 40 ms) and ranged from 4 to 10 M⍀. Membrane conductance was monitored during the experiment using hyperpolarizing pulses (Ϫ10 mV, 75 ms). Electrical stimulation was delivered through a concentric electrode positioned in an area immediately lateral to the posterior SON (Fig. 1A) . Current intensity was increased gradually until EPSCs were evoked by each stimulus (0.2 ms, 50 -300 A). Once per minute, four EPSCs at an interval of 5 s were acquired consecutively and averaged. EPSC duration is the period from the beginning of stimulating pulses to the return of the inward current to baseline, whereas EPSC amplitude refers to the maximal value of the inward current compared with baseline. The change in EPSC was determined by comparing ion currents obtained before and 1, 3, 5, and 10 min after perifusion of slices with test agents. Data acquisition and analyses were performed using a computer operating AXOTAPE and pCLAMP (Axon Instruments). All data are presented as means Ϯ SE and repeated measures ANOVA was applied for statistical analyses.
Chemicals
HA, NE, pyrilamine (H 1 receptor antagonist), dimaprit (H 2 receptor agonist), imetit (H 3 receptor agonist, Tocris, Ballwin, MO), and N -nitro-L-arginine methyl ester (L-NAME) were stored in concentrated solutions (10 Ϫ4 -10 Ϫ2 M) and diluted into ACSF before experiments. 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX, RBI, Natick, MA), 2-amino-5-phosphonovaleric acid (APV), and 8-bromoquanosine 3Ј,5Ј-cyclic monophosphate (8-bromo-cGMP) were directly dissolved in ACSF and applied. When needed, guanosine 5Ј-O-(2-thiodiphosphate) (GDP-␤-S), 1-(5-isoquinolinylsulfonyl)-2-methyl-piperazine (H 7 ), and 1,2-bis(2-aminophenophenoxy)ethane-N,N,NЈ,NЈ-tetraacetic acid (BAPTA) were added to the electrode filling solution and applied intracellularly after membrane rupture. Except where indicated, test agents were usually bolus-injected into perifusion pipeline. It took ϳ30 s before test agents reached the recording chamber, after which the effects of agents were observed. Because of prolonged effects on SON neurons of activating intracellular second-messenger systems (Armstrong and Sladek 1985; Li and Hatton 1996; Li et al. 1999) , such brief exposure of SON cells to HA and NE, provided by bolus injections, achieves a much better recovery rate than bath application. The final concentrations of HA and NE in the recording chamber were ϳ10 M (50 times dilution). Except as otherwise stated, all chemicals used were purchased from Sigma, St. Louis, MO.
Animal care and use during this study were in accordance with National Institutes of Health and institutional guidelines and policy on the use of animals in research. All efforts were made to minimize animal suffering and to reduce the number of animals used.
R E S U L T S
Evoked non-NMDA EPSCs in supraoptic nucleus neurons
Whole cell patch-clamp recordings were obtained from 68 SON neurons. The resting membrane potentials ranged from Ϫ55 to Ϫ75 mV, amplitudes of action potentials from 70 to 100 mV, and membrane input resistances from 0.2 to 0.8 G⍀. In bridge mode without DC current injection, 38% of these cells displayed phasic patterns of firing, with DAPs following spontaneous single spikes. The remaining recorded cells displayed continuous, irregular or burst patterns of firing or were silent. Abundant spontaneous excitatory postsynaptic potentials (EPSPs) were observed routinely, especially when the membrane was hyperpolarized (Fig. 1B) . Electrical stimulation of an area lateral to the posterior SON evoked large (10 -30 mV) EPSPs that often triggered action potentials. These results are consistent with previous reports (for review, see Hatton and Li 1998a ). In SON neurons showing evoked EPSPs, voltage-clamp experiments were carried out and inward postsynaptic currents, i.e., EPSCs, were induced after brief electrical stimulation ( Fig.  2A ). When cells were voltage-clamped at Ϫ70 mV, evoked EPSCs had amplitudes of 88.4 Ϯ 9.6 pA (n ϭ 43). Their rise times ranged from 2-7 ms and durations were 41.1 Ϯ 3.0 ms. With twin stimulus pulses used (20 Hz repeated every 5 s), EPSCs evoked by the second pulse (171.2 Ϯ 11.5 pA, 63.2 Ϯ 4.8 ms; n ϭ 43) were always larger than those by the first pulse (for the amplitude and duration, P Ͻ 0.001 and Ͻ0.05, respectively). Mean paired-pulse facilitation (PPF) ratios were 1.93 Ϯ 0.12. Bath application of 10 -20 M CNQX, a non-NMDA receptor antagonist, for 2 min abolished EPSCs (Fig.  2B ). CNQX did not change the PPF significantly (from 1.91 Ϯ 0.10 in control to 1.64 Ϯ 0.26, P Ͼ 0.05). After bath perifusion of slices with 50 M APV for 10 min, however, EPSCs decreased by ϳ10% (n ϭ 3). These data suggest that EPSCs recorded in the current experiments are predominately gated by non-NMDA (AMPA/kainate) glutamate receptors.
Suppression of EPSCs by histamine
HA effectively suppressed EPSCs in all 15 SON neurons tested (Fig. 3 ). These cells displayed phasic or nonphasic patterns of firing, with or without DAPs. Within 2 min after HA application, EPSC amplitudes and durations decreased by 61.5 and 31.0%, respectively (from 67.5 Ϯ 12.7 pA and 44.9 Ϯ 4.8 ms in control to 26.0 Ϯ 6.4 pA to 31.0 Ϯ 5.4 ms, n ϭ 15; P Ͻ 0.001 for both). Similarly, HA suppressed EPSCs evoked by the second pulses. The amplitudes and durations decreased by 59.4 and 27.5%, resulting in no change in PPF (from 1.87 Ϯ 0.13 in control to 1.95 Ϯ 0.14, n ϭ 15; P Ͼ 0.05). Recovery of EPSCs from HA suppression was readily observed. EPSC amplitudes were 66.8, 86.7, and 95.6% of the control at 3, 5, and 10 min after HA application, whereas EPSC durations were 83.7, 95.6, and 108.5% (n ϭ 15), respectively. Because EPSCs evoked by the second pulses recovered faster, the PPF rose Յ118.2 and 126.2% of the control (1.87 Ϯ 0.13, n ϭ 15) at 3 and 5 min after HA application, although these differences were not statistically significant (P Ͼ 0.05). We examined the dose-response relationship in another five cells, and bath perifusion of HA at concentrations of 0.1, 1, and 10 M suppressed EPSC amplitudes by 21.2, 47.6, and 70.2%, respectively (data not shown).
In contrast to HA, neither dimaprit nor imetit attenuated EPSCs (Fig. 4) . Within 2 min after bolus injection of dimaprit, both EPSC amplitudes durations changed little (from 95.6 Ϯ 12.9 pA and 41.1 Ϯ 6.6 ms in control to 103.7 Ϯ 22.1 pA and 40.5 Ϯ 7.9 ms, n ϭ 5; P Ͼ 0.05 for both). There was also no significant difference in PPF (1.65 Ϯ 0.17 in control to 1.53 Ϯ 0.22; P Ͼ 0.05). EPSC amplitudes and durations were 69.9 Ϯ 8.3 pA and 44.2 Ϯ 4.9 ms in control, and 77.7 Ϯ 17.2 pA and 41.6 Ϯ 5.8 ms within 2 min after imetit injection (n ϭ 7), which are not significantly different (P Ͼ 0.05). The PPF was 1.95 Ϯ 0.17 in control and 2.06 Ϯ 0.23 within 2 min after imetit application (P Ͼ 0.05).
After bath application of 10 -20 M pyrilamine for 5 min, HA induced little change in EPSCs (Fig. 4A) . EPSC amplitudes were 76.6 Ϯ 9.7 pA in control and 70.6 Ϯ 8.2 pA within 2 min after HA injection (n ϭ 8; P Ͼ 0.05), and durations were 38.4 Ϯ 5.6 ms and 42.3 Ϯ 5.4 ms (P Ͼ 0.05, respectively). Similarly, the difference in PPF was also not significant (from 1.56 Ϯ 0.11 to 1.62 Ϯ 0.10; P Ͼ 0.05). These data suggest that HA suppress EPSCs in SON neurons by activating membrane receptors of the H 1 subtype. NE also attenuated EPSCs; these results are described further in a later section.
Effects of histamine after the blockade of intracellular signal transduction in neurons
Histaminergic fibers and H 1 receptors are abundant in the SON, and their distribution patterns suggest that locally released HA can affect not only SON neurons but also other elements such as glia and presynaptic terminals (Inagaki et al. 1988; Kjaer et al. 1994) . The suppression of EPSCs might be mediated by a direct action of HA at SON neurons from which the EPSCs were recorded, by neuromodulators released from neighboring cells after HA application, or by a decrease in transmitter release resulting from the effects of HA and/or neuromodulators on the presynapses. Although the PPF did not increase so greatly as to reach a statistically significant level during HA application, there is still a possibility that presynaptic modulation is partially responsible for EPSC suppression induced by HA. We performed further experiments in the current study, therefore to explore the mechanisms underlying EPSCs suppression.
When patch electrodes containing 0.5 mM GDP-␤-S, a nonhydrolysable GDP analogue, were used to record cells, EPSCs recorded were 145.0 Ϯ 31.1 pA and 68.3 Ϯ 4.1 ms (n ϭ 4), which are not significantly different from EPSCs in control (without GDP-␤-S; P Ͼ 0.05; Fig. 5 ). Within 2 min after HA injection, EPSCs were 73.8 Ϯ 23.0 pA and 39.7 Ϯ 3.3 ms, i.e., reductions of 49.1 and 41.9% in amplitude and duration (P Ͻ 0.05 for both). The PPF went from 1.37 Ϯ 0.17 in control to 1.76 Ϯ 0.62 (P Ͼ 0.05). Intracellular diffusion of (10 mM) BAPTA to chelate intracellular-free Ca 2ϩ , and (0.5 mM) H 7 to antagonize PKC activity, did not abolish HA- induced suppression of EPSCs, either (Fig. 6) . In 11 SON neurons recorded using electrodes containing BAPTA, EPSCs were 132.9 Ϯ 41.2 pA and 38.6 Ϯ 5.2 ms in control and 67.4 Ϯ 24.9 pA and 18.6 Ϯ 4.7 ms 2 min after HA injection, representing suppression by 49.3 and 51.8% in EPSC amplitude and duration, respectively. The change in PPF from 1.79 Ϯ 0.16 in control to 2.05 Ϯ 0.26 was nonsignificant (14.5%; P Ͼ 0.05). When both BAPTA and H 7 were diffused into the cells, HA reduced EPSC amplitudes by 43.9% (from 129.7 Ϯ 10.2 pA to 72.8 Ϯ 23.1 pA; P Ͻ 0.01) and durations by 38.4% (from 59.4 Ϯ 2.6 ms to 36.6 Ϯ 10.4 ms; P Ͻ 0.05). The PPF did not change significantly: 1.72 Ϯ 0.13 in control to 2.19 Ϯ 0.46 2 min after HA application (P Ͼ 0.05). Again, EPSCs recorded using electrodes containing BAPTA and H 7 were not statistically different from those in control (without BAPTA and H 7 ; P Ͼ 0.05). These results suggest that a direct action of HA at SON neurons recorded using patch electrodes is not the primary mechanism underlying EPSC suppression. Rather it seems likely that this effect is indirect and that HA first acts at SON cells (including neurons and nonneurons), resulting in the production of NO, which then induces postsynaptic changes in the SON neurons recorded.
Involvement of NO
Our previous studies have demonstrated that binding of HA to H 1 receptors activates an intracellular signal transduction pathway including G-protein, PLC, inositol 1,4,5-trisphosphate, Ca 2ϩ release from internal stores, and PKC (Li and Hatton 1996; Li et al. 1999) . Ca 2ϩ -calmodulin complex and PKC can further stimulate NOS and increase production of NO and cGMP (Schuman and Madison 1994) . As a result, HA induces prolonged membrane depolarization, enhances DAPs, and facilitates dye transfer among SON neurons (Armstrong and Sladek 1985; Hatton and Yang 1996; Smith and Armstrong 1993) . To investigate whether NO diffusion from neighboring neurons is a potential mechanism for EPSC suppression, we carried out further experiments using cGMP and L-NAME.
Bath perifusion of 1-2 mM 8-bromo-cGMP for 5 min reduced EPSC amplitudes by 32.3% (85.7 Ϯ 17.8 pA in control to 58.0 Ϯ 16.1 pA; n ϭ 4; P Ͻ 0.01) and durations by 27.9% (from 46.3 Ϯ 7.1 to 33.4 Ϯ 9.5 ms; P Ͻ 0.05; Fig. 7 ). There was no change in PPF (from 1.63 Ϯ 0.24 to 2.15 Ϯ 0.65; P Ͼ 0.05). A 90% recovery in EPSC amplitude and duration was observed after washout for 10 min. After bath perifusion of slices with 20 -25 M L-NAME, a NOS inhibitor, for 5 min, HA injection decreased EPSC amplitudes only by 31.9% (from 65.0 Ϯ 3.8 pA in control to 34.3 Ϯ 5.0 pA 2 min after HA application, n ϭ 9; P Ͻ 0.05; Fig. 8A ). This attenuation was much less than that in control (61.5%; P Ͻ 0.01, Student's t-test). In addition, no change in EPSC durations (from 43.6 Ϯ 4.4 to 36.1 Ϯ 5.2 ms; P Ͼ 0.05) or in PPF (1.83 Ϯ 0.13 to 1.90 Ϯ 0.28; P Ͼ 0.05) were observed, suggesting a partial blockade of HA's effect by L-NAME. In SON neurons re- FIG. 7. EPSCs and PPF ratios acquired from a SON neuron showing that membrane-permeable cGMP could mimic HA-induced reduction in EPSCs. s, bath application of 0.5 mM 8-bromoquanosine 3Ј,5Ј-cyclic monophosphate (8-bromocGMP). Note that a bolus injection of NE (1) reduced EPSCs with decreased PPF ratios in this cell. See Fig. 2 for explanation of traces.
FIG. 8. EPSCs acquired from SON neurons perifused with 20 M N
-nitro-L-arginine methyl ester (L-NAME), an inhibitor of nitric oxide synthase. L-NAME prevented EPSC reduction induced by injection of HA, but not by injection of NE in 1 SON neuron tested (A). s, L-NAME application. B: EPSCs obtained from another SON neuron using a patch electrode containing 10 mM BAPTA, a Ca 2ϩ chelator. Chelation of cytosolic Ca 2ϩ did not block HA-or NE-induced reduction in EPSCs. After bath application of L-NAME (20 M), however, HA no longer suppressed EPSCs. See Fig. 2 for explanation of traces. corded using electrodes containing 10 mM BAPTA and perifused with L-NAME, the effects of HA on the EPSCs were abolished completely (Fig. 8B) . The EPSC amplitudes were 119.8 Ϯ 21.8 pA in control and 101.3 Ϯ 27.8 pA within 2 min after HA injection (n ϭ 4; P Ͼ 0.05), whereas durations were 43.3 Ϯ 9.3 and 43.3 Ϯ 6.0 ms, respectively (P Ͼ 0.05). The PPF was 1.61 Ϯ 0.25 and 1.48 Ϯ 0.21 before and 2 min after HA application (P Ͼ 0.05).
Comparison with NE
The SON receives dense noradrenergic innervation from the brain stem nuclei (Armstrong 1995; Hatton 1990 ). Binding to corresponding receptors in the membrane, NE activates intracellular signal pathways, many of which also are involved in mediating the effects of HA on SON neurons (Leurs et al. 1995) . A recent report has demonstrated that NE can suppress inhibitory postsynaptic currents (IPSCs) through a presynaptic mechanism (Wang et al. 1998 ). Therefore we examined whether NE affects EPSCs in SON neurons and compared the effects of NE with those of HA.
The EPSCs, with amplitudes of 72.3 Ϯ 9.4 pA and durations of 34.6 Ϯ 7.1 ms, were obtained from nine SON neurons. Within 1 and 3 min after NE bolus injection, EPSC amplitudes decreased to 46.6 Ϯ 11.0 pA (by 35.6%; P Ͻ 0.01) and 44.0 Ϯ 11.4 pA (by 39.1%; P Ͻ 0.001), respectively (Fig. 4) , whereas durations decreased to 17.1 Ϯ 4.5 ms (by 50.6%; P Ͻ 0.01) and 12.3 Ϯ 4.1 ms (by 64.5%; P Ͻ 0.001). The PPF went from 1.67 Ϯ 0.15 in control to 0.87 Ϯ 0.24 (47.9%; P Ͻ 0.01) within 3 min after NE injection (Figs. 5-7) . The effects of NE on EPSCs were reversible, and 95% recovery from inhibition of EPSC amplitudes and durations was observed 10 min after NE injection. Intracellular diffusion of GDP-␤-S (0.5 mM), H 7 (0.5 mM) and BAPTA (10 mM) did not block NE-induced suppression of EPSCs. EPSC amplitudes were 102.6 Ϯ 9.3 pA in control (n ϭ 20), and decreased to 62.9 Ϯ 8.3 pA (by 38.7%; P Ͻ 0.001) and 45.0 Ϯ 9.7 (by 56.1%; P Ͻ 0.001) within 1 and 3 min after NE injection, respectively. Similar attenuations in EPSC durations and PPF also were observed. In five SON neurons bathed with a medium containing 20 -25 M L-NAME, EPSC amplitudes were reduced from 59.3 Ϯ 10.3 pA in control to 31.4 Ϯ 8.0 pA (by 47.1%; P Ͻ 0.001) and 29.9 Ϯ 9.3 pA (by 49.6%; P Ͻ 0.001) within 1 and 3 min after NE injection, respectively (Fig. 8A) . EPSC durations decreased from 44.0 Ϯ 5.9 ms in control to 22.3 Ϯ 8.4 ms (49.3%; P Ͻ 0.05), whereas the PPF was 1.83 Ϯ 0.10 in control, but decreased to 1.13 Ϯ 0.33 (by 38.3%; P Ͻ 0.05) within 3 min after NE treatment. The combination of perifused L-NAME with intracellular diffusion of BAPTA did not abolish the effects of NE on the EPSCs either (n ϭ 2). These results suggest that NE suppresses EPSCs in SON neurons through presynaptic mechanisms without involving NO production.
D I S C U S S I O N
Neuroendocrine functions in the CNS are subject to continuous control by extrinsic and intrinsic mechanisms to insure proper and prompt responses to environmental stimuli (Hatton 1990; Hatton and Li 1998a) . In this regard, the SON, the magnocellular neurons of which synthesize and store either vasopressin or oxytocin, receive massive neural terminal inputs from other CNS nuclei (Armstrong 1995; Leng et al. 1999 ). Transmitters and/or modulators located at presynaptic terminals in the SON include glutamate, GABA, NE, HA, acetylcholine, ATP, oxytocin, vasopressin, angiotensin, opioid and natriuretic peptides, and interleukins. Many of these substances not only evoke postsynaptic potentials but also activate membrane metabotropic receptors and influence intracellular biochemical processes (Nicoll et al. 1990 ). Besides those direct effects on SON neurons, released substances, i.e., modulators, can influence functions of other synapses. For example, bath application of oxytocin, or inhibitors of aminopeptidase, an enzyme that degrades oxytocin, reduced AMPA currents by ϳ35%, suggesting that endogenous oxytocin can modulate excitatory inputs in the SON (Kombian et al. 1997) . Oxytocin also is known to suppress GABAergic synaptic transmission through postsynaptic mechanisms (Brussaard et al. 1997) . Activation of GABA B receptors presynaptically inhibits AMPA and GABA A currents (Kabashima et al. 1997; Kombian et al. 1996) . In the present study, HA was found to suppress non-NMDA EPSCs in SON neurons by activating H 1 receptors. The suppression was accompanied by little change in the PPF. The effects of HA remained after blockade of G-protein or PKC activation or chelation of intracellular Ca 2ϩ in cells where EPSCs were recorded. EPSC suppression, however, was mimicked by an increase in cytosolic cGMP but partially eliminated by NOS inhibition. When combined with intracellular Ca 2ϩ chelation, NOS inhibition could completely eliminate EPSC suppression induced by HA. These results support the hypothesis that HA induces NO production in SON cells, and then NO postsynaptically suppresses the EPSCs in the same and/or nearby neurons. Bekkers (1993) reported that in isolated or cultured hippocampal pyramidal neurons, HA enhances NMDA, but not AMPA, synaptic currents via activating H 3 receptors. Other studies also showed that HA enhances NMDA currents in hippocampal neurons without involvement of any HA receptor type known (Saybilisi et al. 1995; Vorobjev et al. 1993) . To the best of our knowledge, therefore this is the first report regarding inhibitory effects of HA on non-NMDA synaptic currents via mediation by H 1 receptors.
Constituting more than one-quarter of the nerve terminals on SON neurons (Meeker et al. 1993; van den Pol et al. 1990 ), glutamatergic inputs are critical in the regulation of hypothalamic neuroendocrine activity (Armstrong 1995; Hatton 1990) . Released from presynapses, glutamate can bind to postsynaptic non-NMDA (mainly AMPA) and NMDA receptors to accomplish neurotransmission (Mayer and Westbrook 1987; Ozawa et al. 1998) . SON neurons possess both non-NMDA and NMDA receptors (Meeker et al. 1994a) , the activation of which usually causes membrane depolarization and burst activities (Gribkoff and Dudek 1990; Hu and Bourque 1991; Moos et al. 1997; Wuarin and Dudek 1993; Yang et al. 1995) . In the present study, EPSCs were obtained from SON cells perifused with a medium containing 3 mM Mg 2ϩ and voltageclamped around Ϫ70 mV, procedures that separate non-NMDA currents from NMDA ones (Bekkers and Stevens 1993; Mayer and Westbrook 1987) . Current isolation also was confirmed pharmacologically by application of CNQX and APV (Young and Fagg 1990) , with the former greatly reducing or eliminating the EPSCs and the latter having little effect. These results are consistent with the previous reports showing that in in vitro preparations most excitatory synaptic inputs to SON neurons are mediated by non-NMDA receptors (Gribkoff and Dudek 1990; Kabashima et al. 1997; Kombian et al. 1997; Wuarin and Dudek 1993) .
Being evoked in cells displaying phasic or nonphasic patterns of firing, EPSCs are likely to have been obtained from both vasopressin and oxytocin neurons. There is an increasing body of evidence, however, suggesting that oxytocin and vasopressin neurons are controlled differently by glutamatergic inputs. Immunocytochemical experiments using an antibody against glutamate receptor subunit 3 (GluR3) in the rat hypothalamus reveal that these AMPA receptors are located in the anterodorsal parts of the SON, and 45.8% of oxytocin neurons contain GluR3 immunoreactivity (Ginsberg et al. 1995) . In contrast, only 1.1% of vasopressin neurons were found to be GluR3 immunopositive. Spontaneous miniature AMPA currents have been shown to have larger amplitudes and longer durations in oxytocin, than in vasopressin, neurons (Stern et al. 1999) . Neuronal activities of putative oxytocin neurons, as well as oxytocin release during lactation are preferentially increased by AMPA receptor activation (Parker and Crowley 1993; Richardson and Wakerley 1997) , whereas NMDA receptors are involved in the regulation of rhythmic firing pattern and mediate EPSPs in vasopressin neurons (Hu and Bourque 1992; Moos et al. 1997; . Water deprivation, a strong stimulus for vasopressin secretion due to an increased plasma osmolality and a decreased blood volume, significantly raises NMDA, but not non-NMDA, receptor densities in the SON (Meeker et al. 1994b) . Therefore suppression by HA of non-NMDA EPSCs observed in the present experiments might mainly represent one source of inhibition to oxytocin neurons and thus to oxytocin release.
HA, injected into the brain ventricles or SON, is known to elevate plasma vasopressin concentration and induce antidiuresis (Bennett and Pert 1974; Dogterom et al. 1976; Tuomisto and Eriksson 1979; Tuomisto et al. 1984) . HAergic projections from the TM, and HA receptors have been located in the SON (Inagaki et al. 1988; Palacios et al. 1981; Weiss et al. 1989 ). An increase in HA release in the hypothalamus is detected in response to electrical stimulation of the TM (Akins and Bealer 1993) , dehydration, or injection of hypertonic saline (Akins and Bealer 1990; Kjaer et al. 1994) . HA predominantly excites putative vasopressin SON neurons, enhances DAPs and promotes phasic firing (Armstrong and Sladek 1985; Haas et al. 1975; Li and Hatton 1996; Smith and Armstrong 1993) . In contrast, HA has no effect on, or even hyperpolarizes, the membrane in most oxytocin neurons (Smith and Armstrong 1993) . TM stimulation induces fast IPSPs in oxytocin neurons, and these are blocked by H 2 -antagonists (Yang and Hatton 1994) . There is no direct evidence so far suggesting that HA can increase oxytocin secretion either (Hatton 1990; Onodera et al. 1994) . Taken together, the present results support the hypothesis that HA-induced suppression of EPSCs functions as a supplementary mechanism to coordinate neuroendocrine activities in the SON. Under conditions of increased demand for vasopressin release, HA reduces the AMPA receptor-mediated glutamatergic drive to oxytocin neurons while exciting vasopressin neurons and promoting phasic firing, in such a way as to preferentially restore, e.g., water balance with little change in other neuroendocrine activities. It is also possible that this mechanism participates in preventing premature oxytocin release before parturition, as suggested in one study (Luckman and Larsen 1997) .
Our results imply that HA-induced suppression of EPSCs is mediated by H 1 receptor activation. It is unlikely that H 2 and H 3 receptors are involved because agonists of these receptors failed to mimic the effects of HA. The finding that EPSC suppression was abolished by H 1 receptor antagonism also excludes a direct action of HA at AMPA receptors. H 1 receptors in the membrane usually are coupled to G proteins, and activation of these receptors can increase the activities of PLC, PKC, and NOS, eventually resulting in NO production and raised [Ca 2ϩ ] i (Hatton and Yang 1996; Leurs et al. 1995; Li and Hatton 1996; Li et al. 1999) . Because intracellular diffusion of GDP-␤-S, H 7 , and BAPTA did not interrupt EPSC suppression, it is possible that HA's effects are primarily indirect, i.e., acting at neighboring cells and/or presynaptic terminals first. EPSC suppression could have been a result of local release of neuromodulators after the HA stimulus. A reduction in transmitter release from the presynapses also would cause a similar EPSC suppression. Although many neuromodulators are supposed to be released in response to HA treatment, in the present study we only examined whether NO, a common intercellular modulator (Garthwaite 1991; Zhang and Snyder 1995) , plays any role in HA-induced suppression of EPSCs. NO is known to influence synaptic transmission, often through its actions at postsynaptic NMDA receptors and transmitter secretion (Schuman and Madison 1994) . In the SON, NOS is abundant (Bredt et al. 1990; Calka and Block 1993; Miyagawa et al. 1994; Sanchez et al. 1994) , and NO can increase dye transfer among neurons through gap junctions (Yang and Hatton 1999) and can modulate NMDA currents (Cui et al. 1994 ). The present results showed that NOS inhibition prevented EPSC suppression induced by HA, and cGMP reduced the EPSCs, implying that NO at least partially participates in HA-induced suppression of EPSCs. Our findings are consistent with previous neuroendocrine studies showing that NO controls the release of both vasopressin and oxytocin (Summy-Long et al. 1993; Yasin et al. 1993) . The effects of NO donors on EPSCs were not examined here because NO itself can enhance the release of glutamate, dopamine, serotonin, and acetylcholine from the presynapses (Prast et al. 1996; Schuman and Madison 1994) .
Further experiments are necessary to identify other potential factors or mechanisms underlying EPSC suppression by HA. Indeed, bath application of L-NAME only partially blocked HA-induced suppression of EPSCs. HA is known to raise [Ca 2ϩ ] i by increasing Ca 2ϩ influx through membrane channels and Ca 2ϩ release from internal stores (Leurs et al. 1995; Li et al. 1999) . Because NOS activity is dependent on [Ca 2ϩ ] i , chelation of internal Ca 2ϩ with BAPTA can reduce NO production (Kishi et al. 1996) . On the other hand, BAPTA diffusion also can eliminate activation of other intracellular signal pathways due to raised [Ca 2ϩ ] i . These actions of BAPTA might explain why intracellular diffusion of BAPTA, simultaneously with L-NAME treatment, was needed for complete abolition of EPSC suppression by HA.
Noradrenergic inputs play important roles in the regulation of neuroendocrine secretion in the hypothalamus. The SON receives dense noradrenergic innervation from brain stem nuclei and contains a high density of ␣ 1 receptors, the activation of which can increase activities of G protein, PLC, and PKC and elicits postsynaptic membrane responses in SON neurons (Armstrong 1995; Hatton 1990; Michaloudi et al. 1997; Minneman and Esbenshade 1994) . Like HA, NE can depolarize SON neurons, enhance DAPs, and increase neuronal firing rates (Li et al. 1999; Renaud and Bourque 1991; Yamashita et al. 1987) . NE also has been demonstrated to suppress spontaneous miniature IPSCs in SON neurons by activating ␣ 2 adrenergic receptors in presynaptic terminals (Wang et al. 1998) . In the present experiments, NE and HA reduced non-NMDA currents equally. However, several lines of evidence suggest that NE differs from HA in the mechanisms underlying EPSC modulation. First, NE was found to reduce the EPSCs with a remarkable reduction in the PPF, effects that could not be abolished by intracellular treatments of recorded neurons with GDP-␤-S, H 7 , and BAPTA. Second, the maximal responses to NE were observed usually 3-4 min after NE injection, when EPSC suppression by HA already had started to recover. Third, NOS inhibition abolished HA-, but not NE-, induced suppression of EPSCs. These results suggest that NE suppresses non-NMDA currents via a direct action at the presynapses. In contrast, HA attenuation of EPSCs is unlikely to be via presynaptic mechanisms because there were no significant PPF changes after HA treatment. Although both HA and NE are proposed to function as neuromodulators using common intracellular signal transduction pathways (Nicoll et al. 1990 ), our observations in SON neurons suggest that they can target different sites to bring about a similar effect. As shown in a recent study, both HA and NE enhance the currents underlying DAPs, but only HA's effects are mediated by Ca 2ϩ release from internal stores (Li et al. 1999 ).
In conclusion, the present results suggest that HA suppresses non-NMDA synaptic currents in SON neurons through activation of H 1 receptors and NOS. It is possible that locally released HA, like oxytocin and GABA (Brussaard et al. 1997; Kabashima et al. 1997; Kombian et al. 1996 Kombian et al. , 1997 , can gate neural signals from other CNS neurons by modulating non-NMDA currents to optimize neuroendocrine activities, particularly during dehydration and the late term of pregnancy. Further studies are needed to probe all intracellular signal transduction pathways involved in mediating the effects of HA and NE on EPSCs.
